Background Safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP)
for human immunodeficiency virus (HIV) infection are needed to increase the options …

Importance Preventive interventions are needed to protect residents and staff of skilled
nursing and assisted living facilities from COVID-19 during outbreaks in their facilities. …

Importance The incidence of syphilis in the United States is increasing; it is estimated that
more than 55 000 new infections will occur in 2014. Treatment regimens are controversial, …

Background: The HIV Prevention Trials Network (HPTN) 083 trial demonstrated the
superiority of long-acting injectable cabotegravir (CAB-LA) compared with oral emtricitabine–…

… Bedoya, Clement, and Goldstein received support for article research from the National
Institutes of Health. Dr. Clement received funding from UpToDate (royalties). Dr. Steorts received …

Objective Determine if deep learning detects sepsis earlier and more accurately than other
models. To evaluate model performance using implementation-oriented metrics that simulate …

Recent studies have defined an appropriate CAB LA dosing interval and offered insight into
its safety profile. Phase 3 studies will provide much-anticipated efficacy data. If efficacious, …

Pre-exposure prophylaxis (PrEP) is an effective HIV prevention method, but many primary
care physicians (PCPs) have not incorporated PrEP into practice. While PrEP may be a key …

Background. Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections
are associated with increased risk of cardiovascular disease (CVD). The potential impact of …

Background Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) is
underutilized in the southern United States. Rapid identification of individuals vulnerable to …